Skip to content

A chronopharmacological study of intrathecal sufentanil and ropivacaine for combined spinal-epidural labor analgesia

A chronopharmacological study of intrathecal sufentanil and ropivacaine for combined spinal-epidural labor analgesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067661
Enrollment
Unknown
Registered
2023-01-17
Start date
2023-01-17
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

labor pain

Interventions

Group1 (1:01am-07:00am):None
Group2 (7:01am-1:00pm):None
Group3(1:01pm-7:00pm):None
Group4(7:01pm-1:00pm):None

Sponsors

Xuzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Parturient parturient with head and term who is delivered vaginally 2. Age 20-40 3.ASA Grade II-III 4.18.5<=BMI < 35.5kg/m2 5. Fetal heart monitoring is normal before delivery 6. Have a normal routine (wake up in the morning, go to bed at night)

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to epidural puncture 2. Those who have been confirmed by an obstetrician that vaginal birth is not suitable 3. Delayed or urgent labor 4. Dysfunction of important organs such as heart and lung 5. Have a history of allergy to all related drugs 6. People with mental illness 7. A history of drug or alcohol addiction 8. Use of analgesic medication prior to labor pain relief

Design outcomes

Primary

MeasureTime frame
Duration of analgesia;

Secondary

MeasureTime frame
Adverse reactions during analgesia;

Countries

China

Contacts

Public ContactWang Jinfeng

Xuzhou Central Hospital

jfwmztt@yeah.net+86 181 6877 9112

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026